Published in Gene Therapy Weekly, January 5th, 2012
"Derived from nonpathogenic parvoviruses, these vectors allow for stable and robust expression of desired...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.